Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
0.300
+0.003 (1.04%)
At close: Nov 6, 2024, 4:00 PM
0.285
-0.015 (-5.13%)
Pre-market: Nov 7, 2024, 4:08 AM EST
Bionano Genomics Employees
Bionano Genomics had 344 employees as of December 31, 2023. The number of employees decreased by 61 or -15.06% compared to the previous year.
Employees
344
Change (1Y)
-61
Growth (1Y)
-15.06%
Revenue / Employee
$106,334
Profits / Employee
-$593,317
Market Cap
28.77M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Precision Optics Corporation | 85 |
Spectral AI | 78 |
BioXcel Therapeutics | 74 |
IGC Pharma | 67 |
MiNK Therapeutics | 31 |
Movano | 30 |
NeuroOne Medical Technologies | 16 |
BNGO News
- 3 days ago - Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry - GlobeNewsWire
- 6 days ago - Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - GlobeNewsWire
- 6 days ago - Bionano Adjourns Special Meeting of Stockholders to November 27, 2024 - GlobeNewsWire
- 27 days ago - Bionano Announces Preliminary 3Q 2024 Revenues and Cash - GlobeNewsWire
- 3 months ago - Bionano Genomics, Inc. (BNGO) Canaccord Genuity 44th Annual Growth Conference (Transcript) - Seeking Alpha
- 3 months ago - Bionano Genomics, Inc. (BNGO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress - GlobeNewsWire
- 3 months ago - Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference - GlobeNewsWire